Cytek Bio (CTKB): Net earnings per share (EPS TTM)
Cytek Biosciences, Inc. (CTKB) is recognized as an impeccable technological authority in cellular diagnostics. The rolling earnings per share trend confirms this status, where the -0.63 metric determines the status of the yield parameter. The company generates revenue through the sale of spectral cytometers and associated reagents. Income is based on the creation of innovative analysis systems for medical laboratories and pharmaceutical development.
Analytical breakdowns and data insights for company Cytek Biosciences Inc (CTKB)
- current quotes and average value forecast:
- stock exchange capitalization data:
- business book valuation details:
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio Cytek Biosciences, Inc.|CTKB - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Cytek Bio|CTKB - Company Cumulative Indebtedness|Debts to Book Capitalization Cytek Biosciences, Inc.|CTKB - Long-Term Debt|Company Short-Term Debt Cytek Biosciences|Quick Liquidity Indicator cytekbio.com
- earnings and multiples data:
CTKB - Final Profit|Projected Future Earnings Cytek Biosciences, Inc.|CTKB - Price to Earnings Ratio|Forward P/E Multiple Cytek Biosciences|CTKB - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cytek Biosciences, Inc.|CTKB - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Cytek Biosciences|CTKB - Net earnings per share for the last four quarters|Quarterly EPS earnings growth cytekbio.com|CTKB - Net earnings per share growth this year|Earnings growth forecast for next year Cytek Biosciences, Inc.
Summary company analytics:Cytek Biosciences, Inc. (CTKB)
This indicator reflects the trailing twelve-month net income divided by the total number of shares, allowing for an assessment of the actual return on each share of ownership. The trend in the 12-month per-share net income of Cytek Biosciences, Inc. (CTKB) demonstrates capital sensitivity to specialized medical logistics and equipment calibration costs, directly impacting the final asset management efficiency of Cytek Biosciences, Inc. (CTKB).
Main competitors
A - Earnings per share for the last twelve months|Net earnings per share for the last four quarters questdiagnostics.com DGX|ILMN: Net earnings per share (EPS TTM)|EXAS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months PerkinElmer|Bio-Rad Corp (BIO) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) NNNN|Net earnings per share for the last 12 months soterahealth.com SHC|QuidelOrtho Corporation - Net earnings per share for the last 12 months|OPKO Health Inc (OPK) - Net earnings per one share for the last twelve months|CDNA: Net earnings per share for the last 12 months|Maravai - Earnings per share for the last four quarters|FLGT: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months fluidigm.com (LAB)|Earnings per share for the last twelve months OraSure|Net earnings per share (EPS TTM) Exagen Diagnostics|Net earnings per share for the last 12 months MDXH (MDxHealth Inc.)|LUCD (Lucid Diagnostics, Inc) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) PRE (Prenetics)|Insight Molecular Diagnostics, Inc. - Earnings per share for the last twelve months|Trinity Biotech Corp - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters ProPhase Labs Inc PRPH|Ainos Corp (AIMD) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months CoDx (CODX)|Earnings per share for the last twelve months Heart Test Laboratories|biomerica.com (BMRA) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) CDIO|Net earnings per share for the last 12 months Onconetix Inc ONCO|Net earnings per share (EPS TTM) VRAX (Virax Biolabs Group Ltd)|Net earnings per share for the last four quarters Bluejay Diagnostics Corp (BJDX)|Aspira Women's Health - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months acceleratediagnostics.com|Centogene N.V. (CNTG) - Earnings per share for the last twelve months|Earnings per share for the last 12 months ENZ|FRES (Fresh2 Group Ltd) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months GTG Labs (GENE)|Net earnings per share (EPS TTM) ME|PMD - Net earnings per one share for the last twelve months
